Solstein Capital, LLC Novo Nordisk A S Transaction History

Solstein Capital, LLC

$196 Million
Q3 2024

A detailed history of Solstein Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Solstein Capital, LLC holds 25,837 shares of NVO stock, worth $2.26 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

25,837

Previous 30,837 16.21%

Holding current value

$2.26 Million

Previous $4.4 Million 30.11%

% of portfolio

1.57%

Previous 2.74%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$119.07 - $145.42 $595,350 - $727,099	-5,000 Reduced 16.21%	25,837 $3.08 Million
Q1 2024 Apr 23, 2024	SELL	$102.11 - $135.92 $94,043 - $125,182	-921 Reduced 2.9%	30,837 $3.96 Million
Q4 2023 Jan 22, 2024	BUY	$87.78 - $105.45 $2,457 - $2,952	28 Added 0.09%	31,758 $3.29 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $1.44 Million - $3.17 Million	15,865 Added 100.0%	31,730 $2.89 Million
Q2 2023 Jul 27, 2023	BUY	$155.98 - $172.65 $29,636 - $32,803	190 Added 1.21%	15,865 $2.57 Million
Q1 2023 Apr 19, 2023	SELL	$132.34 - $159.14 $151,529 - $182,215	-1,145 Reduced 6.81%	15,675 $2.49 Million
Q4 2022 Feb 02, 2023	SELL	$102.55 - $135.33 $180,898 - $238,722	-1,764 Reduced 9.49%	16,820 $2.28 Million
Q3 2022 Nov 01, 2022	BUY	$95.28 - $116.93 $13,720 - $16,837	144 Added 0.78%	18,584 $1.85 Million
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $19,925 - $23,509	193 Added 1.06%	18,440 $2.06 Million
Q1 2022 May 05, 2022	SELL	$93.1 - $112.54 $50,646 - $61,221	-544 Reduced 2.9%	18,247 $2.03 Million
Q4 2021 Jan 27, 2022	SELL	$95.88 - $117.08 $37,489 - $45,778	-391 Reduced 2.04%	18,791 $2.11 Million
Q3 2021 Oct 27, 2021	BUY	$84.42 - $106.62 $1.08 Million - $1.36 Million	12,760 Added 198.69%	19,182 $1.84 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $3,044 - $3,814	-45 Reduced 0.7%	6,422 $538,000
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $92,542 - $104,631	1,380 Added 27.13%	6,467 $436,000
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $33,670 - $38,892	527 Added 11.56%	5,087 $356,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $57,321 - $63,198	-900 Reduced 16.48%	4,560 $317,000
Q2 2020 Aug 12, 2020	BUY	$58.54 - $67.94 $319,628 - $370,952	5,460 New	5,460 $358,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Solstein Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Solstein Capital, LLC with notifications on news.

Account

Solstein Capital, LLC Novo Nordisk A S Transaction History